Warning letter
Lavella Brothers: warning letter of Jun 23, 2016
FDA warning letter UCM509003 · Philadelphia District Office
Key facts
| Reference number | UCM509003 |
|---|---|
| Company | Lavella Brothers |
| Subject | CGMP/Manufacturing, Packing or Holding Human Food/Adulterated/Insanitary Conditions |
| Issue date | Jun 23, 2016 |
| Posted date | Jun 23, 2016 |
| Issuing office | Philadelphia District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 1, 110, 110.37, 110.10(b)(8), 110.10(b)(9), 110.20(a)(1), 110.20(b)(7), 110.35(a), 110.35(c), 110.35(d), 110.37(a), 110.37(d)(1) and 4 more |
| Country | 3 |
| Inspection city | Chester |
| Inspection ZIP | 19013 |
| Inspection start date | May 4, 2016 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: